Your browser doesn't support javascript.
loading
Mepolizumab 100 mg in severe asthmatic patients with EGPA in remission phase.
Caminati, Marco; Crisafulli, Ernesto; Lunardi, Claudio; Micheletto, Claudio; Festi, Giuliana; Maule, Matteo; Giollo, Alessandro; Orsolini, Giovanni; Senna, Gianenrico.
Afiliación
  • Caminati M; Department of Medicine, University of Verona and Verona University Hospital, Verona, Italy. Electronic address: marco.caminati@univr.it.
  • Crisafulli E; Department of Medicine, Respiratory Medicine Unit and Section of Internal Medicine, University of Verona and Verona University Hospital, Verona, Italy.
  • Lunardi C; Department of Medicine, University of Verona and Verona University Hospital, Verona, Italy.
  • Micheletto C; Cardio-Thoracic Department, Respiratory Unit, Integrated University Hospital, Verona, Italy.
  • Festi G; Cardio-Thoracic Department, Respiratory Unit, Integrated University Hospital, Verona, Italy.
  • Maule M; Department of Medicine, Specialization Course in Allergy and Clinical Immunology, University of Verona, Verona, Italy.
  • Giollo A; Division of Rheumatology, Department of Medicine, University of Verona and Verona University Hospital, Verona, Italy.
  • Orsolini G; Division of Rheumatology, Department of Medicine, University of Verona and Verona University Hospital, Verona, Italy.
  • Senna G; Department of Medicine, University of Verona and Verona University Hospital, Verona, Italy; Allergy Unit and Asthma Center, Verona University Hospital, Verona, Italy.
J Allergy Clin Immunol Pract ; 9(3): 1386-1388, 2021 03.
Article en En | MEDLINE | ID: mdl-33011303

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndrome de Churg-Strauss / Antiasmáticos Límite: Humans Idioma: En Revista: J Allergy Clin Immunol Pract Año: 2021 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndrome de Churg-Strauss / Antiasmáticos Límite: Humans Idioma: En Revista: J Allergy Clin Immunol Pract Año: 2021 Tipo del documento: Article Pais de publicación: Estados Unidos